MiRNA-200b reverses drug resistance of hepatocellular carcinoma HepG2 cells to sorafenib and its underlying mechanism
Objective To explore the effect of miRNA-200b on sorafenib resistance in hepatocellular carcinoma cells in order to increase the efficacy of the drug in advanced liver cancer patients. Methods Sorafenib resistant hepatocellular carcinoma HepG2-SR cell line was established by gradually increasing th...
Enregistré dans:
Auteurs principaux: | DENG Yong, TANG Tengqian, ZHANG Leida |
---|---|
Format: | article |
Langue: | ZH |
Publié: |
Editorial Office of Journal of Third Military Medical University
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ebebf18ffa6548c1a4574feac02cd3e2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
par: Liming Zheng, et autres
Publié: (2021) -
Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma
par: Elsayed MMA, et autres
Publié: (2019) -
Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma
par: Li Z, et autres
Publié: (2020) -
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
par: Pomej K, et autres
Publié: (2021) -
ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma
par: Wenbin Huang, et autres
Publié: (2021)